Logo

Inscripta: Simon Cawley and Nandini Krishnamurthy

Aug 29, 2019

Genome engineering company Inscripta has named Simon Cawley as the head of computational biology and software engineering, and Nandini Krishnamurthy as the head of microbial genome engineering applications. 

Cawley will be responsible for leading the strategic definition and execution of Inscripta's informatics solutions. He has more than 20 years of bioinformatics experience, and previously served in similar leadership roles at Thermo Fisher Scientific, Life Technologies, Ion Torrent, and Affymetrix. 

Krishnamurthy has more than 15 years of research experience in areas including genetics, computational biology, and genome editing, and has served in various positions at DuPont Pioneer, Genentech, the University of California, Berkeley, and Rockefeller University.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.